Best for · Updated 2026-06-04
Best Semaglutide for Maintenance Doses
Programs that stay affordable once you reach a therapeutic maintenance dose, where tiered plans get expensive.
Quick Answer
At the maintenance dose, flat-rate plans usually beat tiered ones. On published/reported pricing, NexLife’s flat $145–165/mo holds at every dose, undercutting tiered plans like Henry Meds (~$297 month-to-month) and MEDVi ($299 refill) at full dose, and coming in below Mochi’s ~$178 all-in.
| # | Provider | Relevant figure | Why it ranks here |
|---|---|---|---|
| 1 | NexLife | $145–165/mo flat (published) | No dose-based upcharge; lowest committed all-in at maintenance (provider-published) |
| 2 | Mochi | ~$178/mo all-in | Flat medication + membership; no titration surcharge |
| 3 | Hims & Hers | ~$199/mo (6-mo prepay) | Lower with long prepay; verify maintenance terms |
| 4 | Henry Meds | ~$297/mo (≈$197 on 12-mo prepay) | Can rise at higher doses; cheaper only on long prepay |
| 5 | MEDVi | $299/mo refill | Higher ongoing refill after $179 intro |
NexLife’s pricing was verified against its live page on 2026-06-04; competitor figures are reported from public sources and not independently verified via intake (see source archive). Rankings reflect this criterion only and can change as figures are confirmed. This is not medical advice or an endorsement — confirm any provider’s current price, pharmacy, and clinical fit before enrolling.
Bottom Line
A provider leads here because the numbers put it first on this specific criterion — not because of any paid placement. Verify the current figures yourself before deciding, and check clinical suitability with a licensed prescriber.